Daewon Pharmaceutical Co. Ltd. | Balance Sheet
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
26,886
27,815
24,533
18,685
8,303
15,578
Total Accounts Receivable
32,393
31,477
32,005
35,307
49,000
46,843
Inventories
24,085
32,370
31,339
40,564
37,206
44,304
Other Current Assets
277
581
1,042
509
1,278
-
Total Current Assets
83,640
92,243
88,919
95,066
95,788
106,724
Net Property, Plant & Equipment
63,928
76,156
90,331
100,864
108,093
134,683
Total Investments and Advances
932
5,327
6,004
973
2,969
4,837
Long-Term Note Receivable
-
-
252
244
235
3,457
Intangible Assets
8,177
6,822
8,672
9,323
13,924
18,921
Other Assets
3,404
6
-
6,088
2,203
39
Total Assets
160,140
180,617
194,749
214,682
227,202
275,439
ST Debt & Current Portion LT Debt
3,000
3,000
-
-
10,000
Accounts Payable
5,742
3,206
5,484
4,783
4,196
Income Tax Payable
2,125
4,806
4,353
6,255
5,254
Other Current Liabilities
14,227
20,500
20,433
23,796
19,712
Total Current Liabilities
25,094
31,513
30,269
34,835
39,161
Provision for Risks & Charges
9,020
13,558
15,819
17,834
19,911
Deferred Taxes
2,716
971
571
2,125
3,990
Total Liabilities
36,888
46,106
46,088
52,669
59,073
Common Equity (Total)
122,511
133,902
148,188
161,402
167,986
Total Shareholders' Equity
122,511
133,902
148,188
161,402
167,986
Total Equity
123,251
134,511
148,661
162,013
168,129
Liabilities & Shareholders' Equity
160,140
180,617
194,749
214,682
227,202
Accumulated Minority Interest
740
609
473
611
143
About Daewon Pharmaceutical Co.
View Profile
